Fibrinogen-like protein 2 (FGL-2) - a novel biomarker for cancer

被引:0
|
作者
Rabizadeh, E. [1 ]
Lederfine, D. [1 ]
Rosenbaum, E. [2 ]
Brenner, B. [2 ]
Inbal, A. [3 ]
机构
[1] Tel Aviv Univ, Felsenstein Med Res Ctr, Hematooncol Lab, Tel Aviv, Israel
[2] Tel Aviv Univ, Inst Oncol, Beilinson Hosp, Davidoff Canc Ctr, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Thrombosis & Hemostasis Unit, Tel Aviv, Israel
关键词
D O I
10.1016/S0049-3848(12)70136-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S192 / S192
页数:1
相关论文
共 50 条
  • [21] Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
    Denicolo, Sara
    Nair, Viji
    Leierer, Johannes
    Rudnicki, Michael
    Kretzler, Matthias
    Mayer, Gert
    Ju, Wenjun
    Perco, Paul
    BIOMOLECULES, 2023, 13 (01)
  • [22] FIBRINOGEN-LIKE PROTEIN 2 (FGL2) INHIBITS THE ADAPTIVE IMMUNE RESPONSE IN A MODEL OF ACUTE VIRAL HEPATITIS CAUSED BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS
    Khattar, Ramzi
    Yavorska, Nataliya
    Selzner, Nazia
    Shalev, Itay
    Adeyi, Oyedele
    Bartczak, Agata
    Zhang, Jianhua
    Manuel, Justin K.
    Levy, Gary A.
    HEPATOLOGY, 2011, 54 : 492A - 492A
  • [23] Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats
    Xiao-Hua Ye
    Tan-Zhou Chen
    Jia-Ping Huai
    Guang-Rong Lu
    Xiao-Ju Zhuge
    Ren-Pin Chen
    Wu-Jie Chen
    Chen Wang
    Zhi-Ming Huang
    World Journal of Gastroenterology, 2013, (16) : 2492 - 2500
  • [24] Fibrinogen-like protein 2 (FGL2) is a multifaceted immune checkpoint with potential therapeutic application in B-cell non-Hodgkin
    Valero, J. G.
    Sandoval, N.
    Vidal-Crespo, A.
    Berrozpe Casado, B.
    Melchor, J.
    Arenas, F.
    Contreras Grijalba, S.
    Garcia Lacarte, M.
    Colomer, D.
    Roa, S.
    Perez Galan, P.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S170 - S171
  • [25] The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma
    Latha, Khatri
    Yan, Jun
    Yang, Yuhui
    Gressot, Loyola V.
    Kong, Ling-Yuan
    Manyam, Ganiraju
    Ezhilarasan, Ravesanker
    Wang, Qianghu
    Sulman, Erik P.
    Davis, R. Eric
    Huang, Suyun
    Fuller, Gregory N.
    Rao, Arvind
    Heimberger, Amy B.
    Li, Shulin
    Rao, Ganesh
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (03): : 292 - 300
  • [26] Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats
    Ye, Xiao-Hua
    Chen, Tan-Zhou
    Huai, Jia-Ping
    Lu, Guang-Rong
    Zhuge, Xiao-Ju
    Chen, Ren-Pin
    Chen, Wu-Jie
    Wang, Chen
    Huang, Zhi-Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (16) : 2492 - 2500
  • [27] Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment
    Patel, Rajan
    Traylor, Jeffrey I.
    Latha, Khatri
    Heimberger, Amy B.
    Li, Shulin
    Rao, Ganesh
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (08) : 647 - 649
  • [28] Fibrinogen-like protein 2 drives malignant tumor progression in glioma
    Latha, Khatri
    Yan, Jun
    Yang, Yuhui
    Gressot, Loyola V.
    Kong, Lingyuan
    Manyam, Ganiraju
    Ezhilarasan, Ravesanker
    Wang, Qianghu
    Sulman, Erik P.
    Xu, Jingda
    Davis, Richard E.
    Huang, Suyun
    Fuller, Gregory N.
    Rao, Arvind
    Heimberger, Amy B.
    Li, Shulin
    Rao, Ganesh
    CANCER RESEARCH, 2017, 77
  • [29] Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis
    Yanaba, Koichi
    Asano, Yoshihide
    Noda, Shinji
    Akamata, Kaname
    Aozasa, Naohiko
    Taniguchi, Takashi
    Takahashi, Takehiro
    Ichimura, Yohei
    Toyama, Tetsuo
    Sumida, Hayakazu
    Kuwano, Yoshihiro
    Tada, Yayoi
    Sugaya, Makoto
    Kadono, Takafumi
    Sato, Shinichi
    CLINICAL RHEUMATOLOGY, 2013, 32 (01) : 43 - 47
  • [30] Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target
    Fu, Li
    Liu, Zheng
    Liu, Yang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116